Mark Peabody, Executive Vice President and President of Aerospace at Astronics Corp (NASDAQ:ATRO), filed a Form 4 on November 4, 2026, disclosing the exercise of stock options and acquisition of common and Class B shares on November 2, 2026.

Key Highlights

  • Option exercise - common stock: Peabody acquired 4,820 shares of $.01 PV Common Stock via transaction code M at a price of $26.47 per share on November 2, 2026.
  • Option exercise - Class B stock: Peabody acquired 1,831 shares of $.01 PV Class B Stock via transaction code M at a price of $26.47 per share on the same date.
  • Post-transaction ownership: Following the transactions, Peabody directly held 67,607.73 shares of common stock and 234,552 shares of Class B stock, according to the filing.
  • Options exercised to zero: Both option positions exercised on November 2, 2026, originally dated December 14, 2017 with an expiration of December 14, 2026, were reduced to 0 remaining derivative securities.
  • Remaining derivative holdings: Peabody retains multiple option and restricted stock unit positions across both share classes, including options with exercise prices ranging from $8.12 to $29.68 and performance-based RSUs tied to adjusted EBITDA targets.
  • RSU vesting conditions: Performance-based RSUs reported at "target" amounts may vest at between 50% and 150% of the target number depending on Astronics Corp.'s average annual adjusted EBITDA over applicable multi-year periods.

Peabody Exercises Near-Expiry Options in November 2026 Transactions

According to the Form 4 filed with the SEC on November 4, 2026, Mark Peabody, identified as Executive Vice President and President of Aerospace at Astronics Corp, executed two option exercises on November 2, 2026. Both exercises carried a transaction code of M, indicating the conversion of derivative securities into underlying shares. Each set of options carried an exercise price of $26.47 and had been granted on December 14, 2017, with an expiration date of December 14, 2026, making these near-expiry transactions. Following the exercises, both derivative positions were reduced to zero remaining securities, the filing shows.

As a result of the transactions, the filing reports Peabody's direct beneficial ownership at 67,607.73 shares of $.01 PV Common Stock and 234,552 shares of $.01 PV Class B Stock. Beyond the exercised options, the filing discloses that Peabody holds a range of additional option awards with exercise prices of $29.68, $26.31, $25.03, $12.04, $9.28, $8.12, and $12.63, covering both common and Class B stock classes, with expiration dates extending through December 2033.

The filing also details performance-based restricted stock units in both share classes. The RSUs are tied to Astronics Corp.'s average annual adjusted EBITDA over three separate multi-year performance periods ending December 31, 2026, December 31, 2027, and December 31, 2028, respectively. The filing states that "between 50% and 150% of the target number of units may vest" on dates in 2027, 2028, and 2029 depending on actual performance. The form was signed by Julie Davis as Power of Attorney for Mark Peabody and filed on November 4, 2026.

What Was Disclosed

Astronics Corp officer Mark Peabody disclosed the exercise of two stock option grants covering 4,820 common shares and 1,831 Class B shares at $26.47 each on November 2, 2026, plus his remaining derivative and RSU holdings across both share classes.